xRead - September 2022

Wise et al.

Page 172

Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Nothing to disclose

Author

Company

Nature of relationship

Maritta Kilpenäinen, MD, PhD

X

Todd. T. Kingdom, MD

X

Helene Krouse, PhD, ANP BC

X

Desiree Larenas Linnemann, MD

UCB

Advisory board, speaker

Glaxo Smith Kline

Advisory board, speaker, research funding

MEDA

Advisory board, speaker

Astra-Zeneca

Advisory board, speaker, research funding

Armstrong

Advisory board, speaker

Grunenthal

Advisory board, speaker

Novartis

Advisory board, speaker, research funding Advisory board, speaker, research funding

Boehringer Ingelheim

Pfizer

Advisory board, speaker

DBV

Advisory board, speaker

Teva

Research funding

Chiesi

Research funding

Adrienne M. Laury, MD

X

Stella E. Lee, MD

Sanofi-Aventis

Research funding

Allakos

Research funding

Joshua M. Levy, MD, MPH X Amber U. Luong, MD, PhD

ENTvantage Diagnostics

Advisory board, research funding

Aerin Medical

Consultant

480 Biomedical

Consultant

Medtronic

Consultant

Intersect ENT

Research funding

Allakos

Research funding

Bradley F. Marple, MD

X

Edward D. McCoul, MD, MPH K. Christopher McMains, MD

Acclarent

Consultant

X

Erik Melén, MD, PhD

X

James W. Mims, MD

X

Gianna Moscato, MD

X

Joaquim Mullol, MD, PhD

ALK-Abello

Consultant, speaker

Sanofi

Advisory board, consultant

Int Forum Allergy Rhinol . Author manuscript; available in PMC 2020 June 10.